Posidi Tablet 5 mg (Dapagliflozin Monohydrate Mixture)

Adult dose

The recommended dose of this medication is 10 mg once a day for monotherapy and additional combination therapy. For initial combination therapy with metformin, it is 5 mg or 10 mg once a day. This medication can be taken orally once a day at any time, regardless of food intake, and the tablets should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under the age of 18 have not been established. There is no relevant data.

This medication should not be used in certain patients. Patients who are allergic to the active ingredients or excipients of this medication should not take it. This medication should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with inherited conditions that prevent lactose breakdown should not take this medication. It is also not suitable for patients undergoing dialysis. Patients with reduced fluid volume or poor kidney function should use this medication cautiously. This medication can cause blood pressure reduction or changes in kidney function, so these patients should have their fluid status and kidney function carefully evaluated before taking it. During use, symptoms of hypotension or changes in kidney function should be monitored periodically. In patients with moderate to severe reductions in kidney function, blood sugar control effectiveness may decrease, and the decision to administer should be made carefully as needed. This medication contains yellow dye, so patients who are allergic to it should use caution when taking it. This medication can increase the risk of genital infections and urinary tract infections. Especially women and those with a history of infections should be cautious of infection symptoms and receive appropriate treatment if infections occur. If taken with drugs that pose a risk of hypoglycemia, hypoglycemic symptoms may appear, so dosage adjustments may be necessary when combined with insulin or sulfonylureas. Symptoms of dehydration or hypotension due to fluid volume reduction may occur, so particularly elderly patients or those taking diuretics should manage their fluid status closely. This medication can cause serious metabolic abnormalities known as diabetic ketoacidosis, so if symptoms like vomiting, abdominal pain, or difficulty breathing occur, the patient should consult a healthcare provider immediately. It is recommended that pregnant or breastfeeding women do not take this medication, and if pregnancy is confirmed, discontinuation is advised. In the case of overdose, there is no specific antidote, so it is important to receive appropriate treatment based on symptoms. This medication does not significantly affect driving or machinery operation, but caution is needed if there is a risk of hypoglycemia. Always keep out of reach of children and store in the original container to maintain quality.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, difficulty breathing or shortness of breath, asthma attack, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), severe lethargy, sudden and severe headache, thunderclap headache, seizures, confused state of consciousness, visual disturbances, paralysis,

Mild side effects

• Vulvar vulvitis
• balanitis
• urinary tract infections
• fungal infections
• hypoglycemia
• dizziness
• constipation
• dry mouth
• back pain
• dysuria

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree Celsius and 30 degrees Celsius.

Appearance

Yellow, biconvex, round film-coated tablets

Package unit

28 tablets/box [(14 tablets/PTP×2, 7 tablets/PTP×4)]